Search

everythinglearnresearchcommunity

for

Search:↓

Some people experienced hair loss after COVID-19 vaccination, but it's very rare and vaccines' benefits are greater than this risk.

Alopecia areata after COVID-19 vaccination is rare but important to recognize for timely treatment.

Some people developed alopecia areata after COVID-19 vaccination, but it's not caused by the vaccine and most improved with treatment.

People on immune-modifying skin disease treatments may have a weaker antibody response to COVID-19 vaccines but often improve after the second dose.

COVID-19 vaccination may lower vitamin D levels and cause hair loss.

COVID-19 vaccination is generally safe for people with Hidradenitis Suppurativa.

ATP and IL-10 levels in hair follicles relate to follicle length and hair growth, with differences in alopecia patients.

COVID-19 vaccines are safe and highly effective for children, with inactivated vaccines being slightly better.

Encapsulated stem cell exosomes in hydrogel improve wound healing.

Cold atmospheric plasma is a promising and safe treatment for various skin conditions.

lncRNAs influence cashmere fiber traits like diameter and color in goats.

Zinc is crucial for skin health and treating various skin disorders.

Androgens and a high-fat diet may increase the risk of severe COVID-19 in women with PCOS by upregulating certain proteins in the heart and kidneys.

New compounds show promise as nonsteroidal treatments for hair loss.

Insulin resistance increases the risk of developing type 2 diabetes and other health issues.

Keratin 6A increases skin inflammation, suggesting it could be a target for treating certain skin diseases.

Noncoding RNAs help determine cashmere quality in goats.

A genetic mutation in the DCAF17 gene caused Woodhouse-Sakati syndrome in a Chinese patient from a related family.

MicroRNAs are crucial for skin development, regeneration, and disease treatment.

Solid lipid nanoparticles are promising for safe and effective drug delivery but need more research for clinical use.

SARS-CoV-2 proteins help the virus avoid the immune system, delaying response and increasing inflammation.

Men generally face more severe COVID-19 outcomes than women, partly due to hormonal differences.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Some patients on immunosuppressants had a weaker immune response to the Sinovac-CoronaVac COVID-19 vaccine.

Non-coding RNAs are important for hair growth and could lead to new hair loss treatments, but more research is needed.

Africa's low COVID-19 rates may be linked to early measures and possibly higher estrogen levels in women.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Patients with long COVID after Omicron had fewer hospitalizations and milder symptoms but more fatigue, insomnia, and cough compared to those with Delta.

ELIP-based CRISPR delivery improves heart disease gene editing but needs more testing.

The IGRA test effectively detects past SARS-CoV-2 exposure, especially using nucleocapsid peptides.